
|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Care
Author(s)Tracy Lieu, MD, MPH
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Introductionabout 26 years ago
Epidemiology of Pneumococcal Diseaseabout 26 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaabout 26 years ago
Prevention of Pneumococcal Disease in High-Risk Pediatric Groupsabout 26 years ago
The Clinical Impact of Pneumococcal Conjugate Vaccinesabout 26 years ago
Into the Era of the Pneumococcal Conjugate Vaccineabout 26 years ago
Selected Abstractsabout 26 years ago
CME Quizabout 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch
2
Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC
3
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
4
Review Highlights IGHV Testing Complexities in CLL
5















































